Oxypoint is working on the O2NOME project as part of the EU CrossCare project. This project offers a solution for the current problems concerning oxygen therapy in hospitals. The vision of Oxypoint is an optimized oxygen therapy, with more comfort and mobility for the patient. In close collaboration with the Belgian and Dutch testing grounds Licalab and Slimmer Leven, the concept is tested with the various stakeholders in the hospital via iterative co-creation sessions and user tests. By integrating the patented Oxypoint technology and responding to current trends and opportunities such as the Internet of Things (IoT) and personalizing the therapy, Oxypoint hospital brings oxygen therapy to the 21st century.
The project is funded through the CrossCare framework project from the European Interreg Flanders-Netherlands program (www.grensregio.eu). Interreg Flanders-Netherlands encourages cross-border projects for smart, green and inclusive growth, from the European Regional Development Fund (ERDF). You can find more information about the current results on the CrossCare website: www.crosscare.eu.